Pharming Group N.V. (PHAR)
NASDAQ: PHAR · Real-Time Price · USD
11.46
-0.39 (-3.29%)
Aug 24, 2026, 4:00 PM EDT - Market closed

Pharming Group Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
9.32.85-11.84-10.5513.6716
Depreciation & Amortization
11.0110.3210.1910.139.339.17
Other Amortization
0.890.890.850.88--
Loss (Gain) From Sale of Assets
----21.28--
Asset Writedown & Restructuring Costs
0.18-5.034.923.8610.44
Loss (Gain) From Sale of Investments
-2.35-2.35-4.990.93-11.06-0.11
Loss (Gain) on Equity Investments
-0.78-0.621.760.291.08-0.69
Stock-Based Compensation
14.2913.7711.259.256.399.06
Other Operating Activities
6.0819.46-3.975.09-0.44-1.05
Change in Accounts Receivable
-4.39-3.36-6.78-18.542.365.92
Change in Inventory
-4.49-1.29-0.5-14.43-15.02-6.15
Change in Accounts Payable
-0.0614.13-2.7716.2311.99-5.19
Change in Other Net Operating Assets
5.350.9-0.02-0.220.270.47
Operating Cash Flow
35.0354.71-1.8-17.322.4637.84
Operating Cash Flow Growth
12.82%----40.65%-54.75%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.66-0.75-0.79-1.44-1.38-10.74
Cash Acquisitions
--57.48----
Sale (Purchase) of Intangibles
--0.01-0.0121.25-0.6-5.98
Investment in Securities
-84.5884.4832.41-149.27.3-4.59
Other Investing Activities
-0-0----
Investing Cash Flow
-85.2426.2531.62-129.395.32-21.31

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
--104.54---
Long-Term Debt Repaid
--4.25-138.93-4.04-3.31-3.22
Net Debt Issued (Repaid)
-16.36-4.25-34.39-4.04-3.31-3.22
Issuance of Common Stock
23.6219.815.588.132.284.72
Other Financing Activities
-7.96-14.07-5.6-5.13-3.95-29.45
Financing Cash Flow
-0.71.5-34.41-1.04-4.98-27.95

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.77.91-2.212.13-7.38-1.83
Miscellaneous Cash Flow Adjustments
117.8-0----
Net Cash Flow
66.1990.36-6.8-145.615.42-13.24

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
34.3753.96-2.59-18.7421.0827.1
Free Cash Flow Growth
14.02%----22.21%-65.68%
Free Cash Flow Margin
9.38%14.35%-0.87%-7.64%10.25%13.63%
Free Cash Flow Per Share
0.040.07-0.00-0.030.030.04
Levered Free Cash Flow
37.6968.650.248.0616.23-17.14
Unlevered Free Cash Flow
44.5575.355.711.7819.58-13.33

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
6.066.25.65.133.954.45
Cash Income Tax Paid
6.684.615.580.661.24-
Change in Working Capital
-3.610.39-10.07-16.96-0.39-4.96
SEC Filings: 10-K · 10-Q